DUARTE, Calif. & BOSTON--(BUSINESS WIRE)--AccessHope, LLC, a company that provides cancer expertise to employers and their health care partners, today announced a new foundational partnership with Dana-Farber Cancer Institute, extending member access to specialized cancer expertise to more people living with complex cancers across the United States. Dana-Farber joins two National Cancer Institute (NCI)-designated comprehensive cancer centers — City of Hope and Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University — in a novel collaboration that delivers advanced, expert knowledge for employees with cancer and their local treating oncologists, as well as cancer support services.

“The AccessHope program deploys the latest cancer care knowledge to the places and people who need it most, when it is most valuable, wherever they are located,” said AccessHope CEO Mark Stadler. “By adding Dana-Farber as a new foundational partner alongside City of Hope and Northwestern Medicine, we expand our ability to connect plan members with world-renowned specialists who can review their cases and share insights with their local treating oncologists to help improve clinical outcomes, enhance quality of life, and optimize cancer treatment plans.”

Cancer experts from Dana-Farber will provide expertise for AccessHope’s core services — Accountable Precision Oncology, Expert Advisory Review and Cancer Support Team — to employers and their plan members in Northeast states including Massachusetts, Maine, New Hampshire, Vermont, Connecticut, Rhode Island, New York and New Jersey, as well as patients from all across the United States. Through an employer benefit, employees of AccessHope clients have access to AccessHope’s network of oncology experts. The medical specialists are at the forefront of the latest cancer research and lifesaving discoveries, and they can guide individuals and their treating oncologists to the newest personalized treatments, such as clinical trials or breakthrough medications, and genetic/genomic testing and targeted therapies.
Dana-Farber Cancer Institute blends leading science and exceptional care into transformative medicine and is a principal teaching affiliate of Harvard Medical School. Dana-Farber cares for adults and children challenged with cancer, blood disorders and related diseases with world-renowned specialists, providing comprehensive and personalized care for each patient and support for their families.

Rad Oncology Homepage